Fennec Pharmaceuticals Inc.
FRX.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.04M | -14.44M | -436.00K | -1.13M | 2.74M |
| Total Depreciation and Amortization | -698.00K | -697.00K | 0.00 | 774.00K | 749.00K |
| Total Amortization of Deferred Charges | 942.00K | 952.00K | 959.00K | 134.00K | 185.00K |
| Total Other Non-Cash Items | 10.10M | 8.79M | 9.51M | 9.35M | 4.66M |
| Change in Net Operating Assets | -9.99M | -10.99M | 16.94M | 14.47M | 14.71M |
| Cash from Operations | -11.68M | -16.39M | 26.98M | 23.59M | 23.04M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 5.00M | 5.00M |
| Total Debt Repaid | -13.00M | -13.00M | -13.00M | -- | -- |
| Issuance of Common Stock | 1.17M | 1.52M | 1.77M | 1.72M | 1.94M |
| Repurchase of Common Stock | -833.00K | -639.00K | -646.00K | -654.00K | -140.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -1.74M | -1.74M | -1.74M |
| Cash from Financing | -12.67M | -12.12M | -13.62M | 4.33M | 5.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.35M | -28.51M | 13.37M | 27.92M | 28.10M |